 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
The Journal of Neuroscience, February 15, 1999, 19(4):1484-1491
Dopamine Quinone Formation and Protein Modification Associated with the Striatal Neurotoxicity of Methamphetamine: Evidence against a Role for Extracellular Dopamine
Matthew J. LaVoie1 and Teresa G. Hastings1, 2 Departments of 1 Neuroscience and 2 Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261
Methamphetamine-induced toxicity has been shown to require striatal dopamine and to involve mechanisms associated with oxidative stress. Dopamine is a reactive molecule that can oxidize to form free radicals and reactive quinones. Although this has been suggested to contribute to the mechanism of toxicity, the oxidation of dopamine has never been directly measured after methamphetamine exposure. In this study we sought to determine whether methamphetamine-induced toxicity is associated with the oxidation of dopamine by measuring the binding of dopamine quinones to cysteinyl residues on protein. We observed that administration of neurotoxic doses of methamphetamine to rats resulted in a two- to threefold increase in protein cysteinyl-dopamine in the striatum 2, 4, and 8 hr after treatment. When methamphetamine was administered at an ambient temperature of 5°C, no increase in dopamine oxidation products was observed, and toxicity was prevented. Furthermore, as shown by striatal microdialysis, animals treated with methamphetamine at 5°C showed DA release identical to that of animals treated at room temperature. These data suggest that the toxicity of methamphetamine and the associated increase in dopamine oxidation are not exclusively the result of increases in extracellular dopamine. Because dopamine-induced modifications of protein structure and function may result in cellular toxicity, it is likely that dopamine oxidation contributes to methamphetamine-induced toxicity to dopamine terminals, adding support to the role of dopamine and the evidence of oxidative stress in this lesion model.
Key words: cysteinyl-dopamine; dopamine quinone; dopamine oxidation; methamphetamine; neurotoxicity; oxidative stress
Copyright © 1999 Society for Neuroscience 0270-6474/99/1941484-08$05.00/0
This article has been cited by other articles:
J. R. Mazzulli, M. Armakola, M. Dumoulin, I. Parastatidis, and H. Ischiropoulos
Cellular Oligomerization of {alpha}-Synuclein Is Determined by the Interaction of Oxidized Catechols with a C-terminal Sequence
J. Biol. Chem., October 26, 2007; 282(43): 31621 - 31630.
[Abstract] [Full Text] [PDF]
H. A. Boger, L. D. Middaugh, K. S. Patrick, S. Ramamoorthy, E. D. Denehy, H. Zhu, A. M. Pacchioni, A.-C. Granholm, and J. F. McGinty
Long-Term Consequences of Methamphetamine Exposure in Young Adults Are Exacerbated in Glial Cell Line-Derived Neurotrophic Factor Heterozygous Mice
J. Neurosci., August 15, 2007; 27(33): 8816 - 8825.
[Abstract] [Full Text] [PDF]
M. Bisaglia, S. Mammi, and L. Bubacco
Kinetic and Structural Analysis of the Early Oxidation Products of Dopamine: ANALYSIS OF THE INTERACTIONS WITH {alpha}-SYNUCLEIN
J. Biol. Chem., May 25, 2007; 282(21): 15597 - 15605.
[Abstract] [Full Text] [PDF]
E. V. Mosharov, R. G. W. Staal, J. Bove, D. Prou, A. Hananiya, D. Markov, N. Poulsen, K. E. Larsen, C. M. H. Moore, M. D. Troyer, et al.
{alpha}-Synuclein Overexpression Increases Cytosolic Catecholamine Concentration
J. Neurosci., September 6, 2006; 26(36): 9304 - 9311.
[Abstract] [Full Text] [PDF]
D. M. Thomas and D. M. Kuhn
Cyclooxygenase-2 Is an Obligatory Factor in Methamphetamine-Induced Neurotoxicity
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 870 - 876.
[Abstract] [Full Text] [PDF]
D. J. Eyerman and B. K. Yamamoto
Lobeline Attenuates Methamphetamine-Induced Changes in Vesicular Monoamine Transporter 2 Immunoreactivity and Monoamine Depletions in the Striatum
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 160 - 169.
[Abstract] [Full Text] [PDF]
K. A. Mark, J.-J. Soghomonian, and B. K. Yamamoto
High-Dose Methamphetamine Acutely Activates the Striatonigral Pathway to Increase Striatal Glutamate and Mediate Long-Term Dopamine Toxicity
J. Neurosci., December 15, 2004; 24(50): 11449 - 11456.
[Abstract] [Full Text] [PDF]
J. Chen, M. Rusnak, R. R. Luedtke, and A. Sidhu
D1 Dopamine Receptor Mediates Dopamine-induced Cytotoxicity via the ERK Signal Cascade
J. Biol. Chem., September 17, 2004; 279(38): 39317 - 39330.
[Abstract] [Full Text] [PDF]
A. Iwashita, K. Mihara, S. Yamazaki, S. Matsuura, J. Ishida, H. Yamamoto, K. Hattori, N. Matsuoka, and S. Mutoh
A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1114 - 1124.
[Abstract] [Full Text] [PDF]
J. C. Bemis and R. F. Seegal
PCB-Induced Inhibition of the Vesicular Monoamine Transporter Predicts Reductions in Synaptosomal Dopamine Content
Toxicol. Sci., August 1, 2004; 80(2): 288 - 295.
[Abstract] [Full Text] [PDF]
A. J. Baucum II, K. S. Rau, E. L. Riddle, G. R. Hanson, and A. E. Fleckenstein
Methamphetamine Increases Dopamine Transporter Higher Molecular Weight Complex Formation via a Dopamine- and Hyperthermia-Associated Mechanism
J. Neurosci., March 31, 2004; 24(13): 3436 - 3443.
[Abstract] [Full Text] [PDF]
J. L. CADET, S. JAYANTHI, and X. DENG
Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis
FASEB J, October 1, 2003; 17(13): 1775 - 1788.
[Abstract] [Full Text] [PDF]
S. Park, T. J. Geddes, J. A. Javitch, and D. M. Kuhn
Dopamine Prevents Nitration of Tyrosine Hydroxylase by Peroxynitrite and Nitrogen Dioxide: IS NITROTYROSINE FORMATION AN EARLY STEP IN DOPAMINE NEURONAL DAMAGE?
J. Biol. Chem., August 1, 2003; 278(31): 28736 - 28742.
[Abstract] [Full Text] [PDF]
X. Deng, S. Jayanthi, B. Ladenheim, I. N. Krasnova, and J. L. Cadet
Mice with Partial Deficiency of c-Jun Show Attenuation of Methamphetamine-Induced Neuronal Apoptosis
Mol. Pharmacol., November 1, 2002; 62(5): 993 - 1000.
[Abstract] [Full Text] [PDF]
K. E. Larsen, E. A. Fon, T. G. Hastings, R. H. Edwards, and D. Sulzer
Methamphetamine-Induced Degeneration of Dopaminergic Neurons Involves Autophagy and Upregulation of Dopamine Synthesis
J. Neurosci., October 15, 2002; 22(20): 8951 - 8960.
[Abstract] [Full Text] [PDF]
J. Lotharius and P. Brundin
Impaired dopamine storage resulting from {alpha}-synuclein mutations may contribute to the pathogenesis of Parkinson's disease
Hum. Mol. Genet., October 1, 2002; 11(20): 2395 - 2407.
[Abstract] [Full Text] [PDF]
G. Battaglia, F. Fornai, C. L. Busceti, G. Aloisi, F. Cerrito, A. De Blasi, D. Melchiorri, and F. Nicoletti
Selective Blockade of mGlu5 Metabotropic Glutamate Receptors Is Protective against Methamphetamine Neurotoxicity
J. Neurosci., March 15, 2002; 22(6): 2135 - 2141.
[Abstract] [Full Text] [PDF]
J. P. Hansen, E. L. Riddle, V. Sandoval, J. M. Brown, J. W. Gibb, G. R. Hanson, and A. E. Fleckenstein
Methylenedioxymethamphetamine Decreases Plasmalemmal and Vesicular Dopamine Transport: Mechanisms and Implications for Neurotoxicity
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 1093 - 1100.
[Abstract] [Full Text] [PDF]
A. Heller, N. Bubula, R. Lew, B. Heller, and L. Won
Gender-Dependent Enhanced Adult Neurotoxic Response to Methamphetamine following Fetal Exposure to the Drug
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 769 - 779.
[Abstract] [Full Text] [PDF]
S. JAYANTHI, X. DENG, M. BORDELON, M. T. MCCOY, and J. L. CADET
Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex
FASEB J, August 1, 2001; 15(10): 1745 - 1752.
[Abstract] [Full Text] [PDF]
B. Ladenheim, I. N. Krasnova, X. Deng, J. M. Oyler, A. Polettini, T. H. Moran, M. A. Huestis, and J. L. Cadet
Methamphetamine-Induced Neurotoxicity Is Attenuated in Transgenic Mice with a Null Mutation for Interleukin-6
Mol. Pharmacol., April 13, 2001; 58(6): 1247 - 1256.
[Abstract] [Full Text]
R. R. Metzger, H. M. Haughey, D. G. Wilkins, J. W. Gibb, G. R. Hanson, and A. E. Fleckenstein
Methamphetamine-Induced Rapid Decrease in Dopamine Transporter Function: Role of Dopamine and Hyperthermia
J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1077 - 1085.
[Abstract] [Full Text]
J. F. Bowyer, G. D. Newport, W. Slikker Jr., B. Gough, S. A. Ferguson, and J. Tor-Agbidye
An Evaluation of l-Ephedrine Neurotoxicity with Respect to Hyperthermia and Caudate/Putamen Microdialysate Levels of Ephedrine, Dopamine, Serotonin, and Glutamate
Toxicol. Sci., May 1, 2000; 55(1): 133 - 142.
[Abstract] [Full Text] [PDF]
K. B. Burrows, W. L. Nixdorf, and B. K. Yamamoto
Central Administration of Methamphetamine Synergizes with Metabolic Inhibition to Deplete Striatal Monoamines
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 853 - 860.
[Abstract] [Full Text]
X. Deng, B. Ladenheim, L.-I Tsao, and J. L. Cadet
Null Mutation of c-fos Causes Exacerbation of Methamphetamine-Induced Neurotoxicity
J. Neurosci., November 15, 1999; 19(22): 10107 - 10115.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|